Multistep carcinogenesis in anaplastic thyroid carcinoma: A case report

被引:19
作者
Asakawa, H
Kobayashi, T
机构
[1] Itami City Hosp, Itami, Hyogo 6648540, Japan
[2] Ikeda City Hosp, Osaka, Japan
关键词
anaplastic thyroid carcinoma cell line; N-ras; p53;
D O I
10.1080/00313020120105732
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We previously established an anaplastic thyroid carcinoma cell line (KOA2) that had double mutations: an N-ras mutation and a p53 gene mutation. To clarify multistep carcinogenesis, we analysed surgical material from the patient from whom KOA2 was derived for abnormalities in the N-ras and p53 genes. The resected material had two histologically different lesions: a follicular neoplasm and an anaplastic carcinoma. The N-ras mutation was observed in both lesions, but the p53 gene mutation only in the anaplastic lesion. These facts indicate that an N-ras mutation may induce follicular neoplasm and a subsequent p53 mutation may have caused the follicular neoplasm to transform to anaplastic carcinoma in this patient. This report suggests direct evidence for multistep carcinogenesis in anaplastic thyroid carcinoma.
引用
收藏
页码:94 / 97
页数:4
相关论文
共 21 条
[1]   EXPRESSION OF ONCOGENES IN THYROID-TUMORS - COEXPRESSION OF C-ERBB2/NEU AND C-ERBB [J].
AASLAND, R ;
LILLEHAUG, JR ;
MALE, R ;
JOSENDAL, O ;
VARHAUG, JE ;
KLEPPE, K .
BRITISH JOURNAL OF CANCER, 1988, 57 (04) :358-363
[2]   Effects of interleukin-1 beta on scanning electron microscopic appearance and thyroid peroxidase content of human thyrocytes in monolayer culture [J].
Asakawa, H ;
Miyagawa, J ;
Kobayashi, T ;
Hanafusa, T ;
Kuwajima, M ;
Matsuzawa, Y .
IMMUNOPHARMACOLOGY, 1996, 34 (2-3) :131-137
[3]   HUMAN RECOMBINANT INTERLEUKIN-1 INHIBITS TSH-STIMULATED MORPHOLOGICAL-CHANGES IN THYROID-FOLLICLES CULTURED AS SEMI-ORGANS [J].
ASAKAWA, H ;
HANAFUSA, T ;
ODA, Y ;
KATSURA, H ;
MIYAGAWA, J ;
MASHITA, K ;
KONO, N ;
TARUI, S .
ACTA ENDOCRINOLOGICA, 1991, 125 (01) :80-85
[4]  
Asakawa H, 1999, ANTICANCER RES, V19, P761
[5]   Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis [J].
Asakawa, H ;
Kobayashi, T ;
Komoike, Y ;
Yanagawa, T ;
Takahashi, M ;
Wakasugi, E ;
Maruyama, H ;
Tamaki, Y ;
Matsuzawa, Y ;
Monden, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) :3547-3552
[6]  
BATTISTA S, 1995, ONCOGENE, V11, P2029
[7]   HUMAN RECOMBINANT INTERLEUKIN-1-BETA DECREASES PLASMA THYROID-HORMONE AND THYROID STIMULATING HORMONE LEVELS IN RATS [J].
DUBUIS, JM ;
DAYER, JM ;
SIEGRISTKAISER, CA ;
BURGER, AG .
ENDOCRINOLOGY, 1988, 123 (05) :2175-2181
[8]   HIGH PREVALENCE OF MUTATIONS OF THE P53 GENE IN POORLY DIFFERENTIATED HUMAN THYROID CARCINOMAS [J].
FAGIN, JA ;
MATSUO, K ;
KARMAKAR, A ;
CHEN, DL ;
TANG, SH ;
KOEFFLER, HP .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :179-184
[9]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[10]   p53 gene mutations in radiation-induced thyroid cancer [J].
Fogelfeld, L ;
Bauer, TK ;
Schneider, AB ;
Swartz, JE ;
Zitman, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :3039-3044